| 臺大學術典藏 |
2019-08-29T07:30:08Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Chen-Hua Liu;Tung-Hung Su;Chun-Jen Liu;Chun-Ming Hong;Hung-Chih Yang;Tseng, Tai-Chung;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; CHEN-HUA LIU; TUNG-HUNG SU; CHUN-JEN LIU; CHUN-MING HONG; HUNG-CHIH YANG; Tseng, Tai-Chung; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-01-24T09:31:13Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Liu C.-H.; Su T.-H.; CHUN-JEN LIU; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:22Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
CHEN-HUA LIU; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-06-25T08:10:13Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Liu C.-H.; Su T.-H.; Liu C.-J.; CHUN-MING HONG; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:16:48Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Liu C.-H.; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-07-12T02:44:27Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Liu C.-H; | Su T.-H; | Liu C.-J; | Hong C.-M; | HUNG-CHIH YANG; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:17Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Liu C.-H.; TUNG-HUNG SU; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-06-14T23:24:05Z |
Sofosbuvir-based direct-acting antivirals for patients with decompensated hepatitis C virus-related cirrhosis
|
CHEN-HUA LIU; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:20Z |
Sofosbuvir-based direct-acting antivirals for patients with decompensated hepatitis C virus-related cirrhosis
|
Liu C.-H.; Liu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:03:46Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu, C.-H.;Chen, Y.-S.;Wang, S.-S.;Liu, C.-J.;Su, T.-H.;Yang, H.-C.;Hong, C.-M.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; DING-SHINN CHEN; CHUN-MING HONG; JIA-HORNG KAO |
| 臺大學術典藏 |
2019-11-27T06:54:22Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu C.-H.;Yih-Sharng Chen;Wang S.-S.;Liu C.-J.;Su T.-H.;Yang H.-C.;Hong C.-M.;Chen P.-J.;Chen D.-S.;Kao J.-H.; Liu C.-H.; YIH-SHARNG CHEN; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2020-03-05T08:37:30Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Kao J.-H.; Chen D.-S.; Liu C.-H.; Chen Y.-S.; SHOEI-SHEN WANG; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J. |
| 臺大學術典藏 |
2021-03-09T01:43:24Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-06-25T08:10:15Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:33:41Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-12T02:44:33Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu C.-H; | Chen Y.-S; | Wang S.-S; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Chen P.-J; | Chen D.-S; | Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:21Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu C.-H.; Chen Y.-S.; Wang S.-S.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:17:10Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-05-24T07:20:28Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
CHEN-HUA LIU; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 中山醫學大學 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
| 臺大學術典藏 |
2022-01-24T09:30:59Z |
Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; CHUN-JEN LIU; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:27Z |
Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-02-22T05:34:10Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-02-23T02:12:21Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-01-15T00:07:58Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, Pin Nan; Mo, Lein Ray; CHUN-TING CHEN; Chen, Chi Yi; Huang, Chung Feng; Kuo, Hsing Tao; Lo, Ching Chu; Tseng, Kuo Chih; Huang, Yi Hsiang; Tai, Chi Ming; Peng, Cheng Yuan; Bair, Ming Jong; CHIEN-HUNG CHEN; Yeh, Ming Lun; Lin, Chih Lang; Lin, Chun Yen; Lee, Pei Lun; Chong, Lee Won; Hung, Chao Hung; Chang, Te Sheng; Huang, Jee Fu; Yang, Chi Chieh; Hu, Jui Ting; Lin, Chih Wen; CHIA-CHI WANG; Su, Wei Wen; Hsieh, Tsai Yuan; Lin, Chih Lin; Tsai, Wei Lun; Lee, Tzong Hsi; Chen, Guei Ying; Wang, Szu Jen; Chang, Chun Chao; Yang, Sheng Shun; Wu, Wen Chih; Huang, Chia Sheng; Chou, Kwok Hsiung; Kao, Chien Neng; Tsai, Pei Chien; CHEN-HUA LIU; Lee, Mei Hsuan; Cheng, Chien Yu; Tsai, Ming Chang; CHUN-JEN LIU; Dai, Chia Yen; Lin, Han Chieh; JIA-HORNG KAO; Chuang, Wan Long; Yu, Ming Lung |
